Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

286 questions in 57 reviews · Developmental, Psychosocial and Learning Problems

current versions
No studies 286 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Physical activity interventions with a caregiver component vs interventions without a caregiver component
Children's sodium intake (not measured) · children aged 3 to 11 years
Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) vs vitamin D (lower dose)
Stuntingc · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) vs vitamin D (lower dose)
Adverse effect: hyperphosphataemiac · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) vs vitamin D (lower dose)
Adverse effect: kidney stonesc · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) + micronutrient(s) vs vitamin D (lower dose) + micronutrient(s)
Length/height‐for‐age z‐score (L/HAZ)b · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) + micronutrient(s) vs vitamin D (lower dose) + micronutrient(s)
Stuntingb · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) + micronutrient(s) vs vitamin D (lower dose) + micronutrient(s)
Adverse effect: hyperphosphataemiab · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D (higher dose) + micronutrient(s) vs vitamin D (lower dose) + micronutrient(s)
Adverse effect: kidney stonesb · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D vs placebo or no intervention
Adverse effect: hyperphosphataemiae · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Vitamin D vs placebo or no intervention
Adverse effect: kidney stonese · children under 5 years of age
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under… (2020) · Cochrane
no estimate extractedNRNo studies
Psychotherapy vs waiting list or no treatment
Adverse effects (not measured · borderline personality disorder
Psychological therapies for people with borderline personality disorder (2020) · Cochrane
no estimate extractedNRNo studies
Dialectical behavioural therapy or mentalisation‐based therapy vs treatment‐as‐usual
DBT · borderline personality disorder
Psychological therapies for people with borderline personality disorder (2020) · Cochrane
no estimate extractedNRNo studies
Dialectical behavioural therapy or mentalisation‐based therapy vs treatment‐as‐usual
MBT · borderline personality disorder
Psychological therapies for people with borderline personality disorder (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training without body weight support vs the same dose of overground walking training
Quality of life (not measured) · children with cerebral palsy classified within GMFCS Levels I to III and between 3 and 12 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training with body weight support vs the same dose of overground walking training
Adverse events (not measured) · children with cerebral palsy classified within GMFCS Levels I to IV and between 4 and 18 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training with body weight support vs the same dose of overground walking training
Quality of life (not measured) · children with cerebral palsy classified within GMFCS Levels I to IV and between 4 and 18 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training without body weight support vs no walking training
Participation (not measured) · children with cerebral palsy classified within GMFCS Levels I to III between 5 and 19 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training without body weight support vs no walking training
Quality of life (not measured) · children with cerebral palsy classified within GMFCS Levels I to III between 5 and 19 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
Mechanically assisted walking training without body weight support vs the same dose of overground walking training
Adverse events (not measured) · children with cerebral palsy classified within GMFCS Levels I to III and between 3 and 12 years of age
Mechanically assisted walking training for walking, participation, and quality of life in children with… (2020) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Instrumented gait analysis (kinematics) (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Instrumented gait analysis (kinematics) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Observational gait analysis (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Observational gait analysis (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs placebo or sham
Instrumented gait analysis (kinematics) (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs placebo or sham
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs placebo or sham
Instrumented gait analysis (kinematics) (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs placebo or sham
Observational gait analysis (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs placebo or sham
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Instrumented gait analysis (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Observational gait analysis (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Satisfaction (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Adverse events (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Instrumented gait analysis (kinematics) (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Manual ability ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Unimanual capacity ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Manual Ability ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Self‐care ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Individualised measures of performance ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs low‐dose comparison
Manual ability ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs low‐dose comparison
Self‐care ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs low‐dose comparison
Individualised measures of performance ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies